Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity.
about
Using Yeast Synthetic Lethality To Inform Drug Combination for Malaria.Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery.Validation of Babesia proteasome as a drug targetAntimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance
P2860
Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Development of a Potent Inhibi ...... th Reduced Mammalian Toxicity.
@en
type
label
Development of a Potent Inhibi ...... th Reduced Mammalian Toxicity.
@en
prefLabel
Development of a Potent Inhibi ...... th Reduced Mammalian Toxicity.
@en
P2093
P2860
P50
P1476
Development of a Potent Inhibi ...... th Reduced Mammalian Toxicity.
@en
P2093
Anthony J O'Donoghue
Betsaida Bibo-Verdugo
Bing Yu Zou
Colleen A Boyle
Edgar Vigil
Gregory M Goldgof
Gregory M LaMonte
Jehad Almaliti
Jennifer Yang
Lawrence Wang
P2860
P304
P356
10.1021/ACS.JMEDCHEM.7B00671
P407
P577
2017-07-11T00:00:00Z